News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
142,984 Results
Type
Article (7858)
Company Profile (38)
Press Release (135088)
Section
Business (43466)
Career Advice (236)
Deals (5201)
Drug Delivery (12)
Drug Development (21192)
Employer Resources (35)
FDA (2570)
Job Trends (3617)
News (71932)
Policy (5191)
Tag
Academia (902)
Alliances (11986)
Alzheimer's disease (511)
Approvals (2559)
Artificial intelligence (46)
Bankruptcy (31)
Best Places to Work (3189)
Breast cancer (73)
Cancer (446)
Cardiovascular disease (49)
Career advice (219)
CAR-T (33)
Cell therapy (82)
Clinical research (16299)
Collaboration (163)
COVID-19 (688)
C-suite (54)
Cystic fibrosis (33)
Data (526)
Diabetes (42)
Diagnostics (1516)
Earnings (10805)
Employer resources (33)
Events (22112)
Executive appointments (155)
FDA (2724)
Funding (155)
Gene therapy (56)
GLP-1 (154)
Government (899)
Healthcare (3857)
Infectious disease (711)
Inflammatory bowel disease (40)
Interviews (32)
IPO (2033)
Job creations (622)
Job search strategy (200)
Layoffs (83)
Legal (873)
Lung cancer (58)
Manufacturing (39)
Medical device (1779)
Medtech (1781)
Mergers & acquisitions (3244)
Metabolic disorders (119)
Neuroscience (610)
NextGen: Class of 2025 (1272)
Non-profit (1393)
Northern California (459)
Obesity (66)
Opinion (42)
Parkinson's disease (35)
People (17865)
Phase I (4860)
Phase II (6898)
Phase III (5687)
Pipeline (156)
Postmarket research (663)
Preclinical (3157)
Press Release (33)
Radiopharmaceuticals (45)
Rare diseases (83)
Real estate (1211)
Regulatory (3774)
Research institute (1020)
Series A (43)
Southern California (359)
Startups (1177)
United States (4009)
Vaccines (110)
Weight loss (32)
Date
Today (23)
Last 7 days (228)
Last 30 days (527)
Last 365 days (8856)
2025 (332)
2024 (8873)
2023 (10131)
2022 (12898)
2021 (14119)
2020 (12485)
2019 (10037)
2018 (7699)
2017 (7858)
2016 (7578)
2015 (8161)
2014 (5961)
2013 (4756)
2012 (4881)
2011 (5147)
2010 (4330)
Location
Africa (159)
Asia (7862)
Australia (1341)
California (962)
Canada (411)
China (62)
Colorado (51)
Connecticut (51)
Europe (21677)
Florida (101)
Georgia (35)
Illinois (78)
Indiana (42)
Maine (33)
Maryland (115)
Massachusetts (917)
Michigan (63)
Minnesota (53)
New Jersey (271)
New York (342)
North Carolina (175)
Northern California (459)
Ohio (53)
Pennsylvania (233)
South America (195)
Southern California (359)
Texas (163)
Utah (43)
Washington State (110)
142,984 Results for "semler scientific".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Semler Scientific® Reports First Quarter 2024 Financial Results
Semler Scientific, Inc. reported financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
9 min read
Business
Semler Scientific to Report First Quarter Financial Results and Host Conference Call on May 7, 2024
Semler Scientific, Inc. today announced that it will report financial results for the first quarter ended March 31, 2024, after the close of U.S. financial market.
April 23, 2024
·
2 min read
Business
Semler Scientific Reports Fourth Quarter and Full Year 2023 Financial Results
Semler Scientific, Inc., a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, reported financial results for the fourth quarter and full year ended December 31, 2023.
March 5, 2024
·
11 min read
Biotech Bay
Semler Scientific to Report Fourth Quarter and Year End 2023 Financial Results and Host Conference Call on March 5, 2024
Semler Scientific, Inc. today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023, after the close on Tuesday, March 5, 2024.
February 21, 2024
·
2 min read
Business
Semler Scientific Announces Appointment of Eric Semler and William Chang as Directors
- Semler Scientific, Inc. announced that Eric Semler and William H.C. Chang, who collectively beneficially own more than 20% of Semler Scientific’s outstanding shares, will immediately join Semler Scientific’s board of directors as new independent directors.
April 19, 2023
·
8 min read
Biotech Bay
Semler Scientific to Present at Upcoming September 2023 Investor Conference
Semler Scientific, Inc., a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, announced Renae Cormier, CFO, will participate in the following investor conference.
August 31, 2023
·
1 min read
Biotech Bay
Semler Scientific to Join the Russell 2000® and 3000® Indexes
Semler Scientific, Inc. announced that it is set to join the Russell 2000® and 3000® Indexes at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens on June 26, 2023.
June 23, 2023
·
3 min read
Business
Semler Scientific Reports Second Quarter and First Half of 2023 Financial Results
Semler Scientific, Inc., a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, reported financial results for the three and six months ended June 30, 2023.
August 10, 2023
·
10 min read
Business
Semler Scientific Announces Appointment of Chief Financial Officer, Record Quarterly Revenues and Strategic Streamlining
Semler Scientific, Inc. today announced the appointment of a chief financial officer (CFO), record quarterly revenues expected for the second quarter of 2023 and a strategic streamlining.
July 11, 2023
·
5 min read
Business
Semler Scientific to Report Third Quarter and First Nine Months of 2023 Financial Results and Host Conference Call on November 9, 2023
Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the third quarter and first nine months ended September 30, 2023, after the close of U.S. financial markets on Thursday, November 9, 2023.
October 26, 2023
·
2 min read
1 of 14,299
Next